Illumina Inc
NASDAQ: ILMN
$144.52
+$4.38 (+3.1%)
Real Time Data Delayed 15 Min.
ILMN Articles
2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks, albeit with lower rewards than seen in 2009 as there have been far fewer ten-baggers with...
Published:
Last Updated:
These are this morning’s top day trader and active trader alerts from us with links through to updates and more detailed price-volume analysis with a link to each stock at VSInvestor.com: Advanced...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street early this Thursday morning: Amdocs (DOX) Raised to Outperform at Oppenheimer. Chevron (CVX)...
Published:
These are some of the top upgrades or positive calls we are seeing from analysts this Friday morning: Home Depot (HD) Started as Outperform at FBR. Illumina (ILMN) Started as Overweight at Morgan...
Published:
Illumina Inc. (NASDAQ: ILMN) has priced its proposed secondary offering of 3.5 million shares at $87.50 per share. This will result in net proceeds of roughly $297.9 million. The sole manager of...
Published:
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates and...
Published:
These are not the only big analysts calls this Friday morning, but these are the ones that 24/7WallSt.com is focusing on this morning: Bear Stearns (BSC) raised to Buy at Merrill Lynch. Continental...
Published:
ACL started as Buy at Jefferies.AMGN started as Mkt Perform at Rodman & Renshaw.B started as Outperform at CIBC.CBB started as Buy at UBS.CHE started as Buy at Jefferies.CTL raised to Neutral at...
Published: